Thomas Swan, a producer of specialty chemicals, has announced that it has completed the purchase of a specialty chemicals manufacturing facility at Opelika, Alabama, formerly owned by Apollo Chemicals, part of the Mount Vernon Chemicals group. No products from Mount Vernon Chemicals were included in the purchase.
The acquisition follows increased demand from Thomas Swan’s contract manufacture customers for glass-lined manufacturing capacity in the United States. Thomas Swan says it is planning a major overhaul and upgrade of the facility to a state-of-the-art, flexible plant for the custom manufacture of specialty chemicals. Significant glass-lined reactor capacity will be included in the design, the company says.
“Existing custom manufacturing customers have asked us to add US manufacturing capability, providing a strong business case for this acquisition,” says Tom Porter, business director of the custom manufacturing division at Thomas Swan. “We will shortly commence the process of fitting it out to allow significant room for sales growth, with the site capable of large future expansion in addition to the current plans,” Porter says.
Specific available capacity will include glass-lined, acid-resistant production and distillation capability with a volume up to 10 cubic meters; stainless steel reactor and distillation capability with a volume up to 8 cubic meters; reaction vessels and instrumentation controlled by the Emerson DeltaV control system; and bulk storage with tanker loading and off-loading facilities.
“This is a major step in the implementation of our global expansion strategy and will provide a valuable manufacturing hub for us in the United States,” says Harry Swan, managing director, Thomas Swan. “We expect the Opelika plant to support our continued recent growth in custom manufacture by opening up the US market to us. Flexible, glass-lined capacity is rare in the United States, especially at the mid-scale that we will offer,” Swan says.
By Michael Ravenscroft
Source: Chemical Week
Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.
OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.
The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.